Back to search

National and Kapodistrian University of Athens

Μελέτη της συχνότητας και βαρύτητας των επιπλοκών της ενδιάμεσης β-μεσογειακής αναιμίας σε Έλληνες ασθενείς: συσχέτιση με το γονότυπο

Abstract

dc:description

Τhe clinical course and complications of β-thalassemia intermedia in the Greek population and their correlation with the molecular and hematological data was studied in 98 β-thalassemia intermedia patients. Of them 94 (95.9%) had two βthal or δβ mutations and 4 (4.1%) were β-thalassemia heterozygotes with triplicated a gene (ααα/αα) or (ααα/ααα). Based on clinical and haematological data, patients were classified into two clinical phenotypes (I1 severe, I2 mild). Τhe age at diagnosis ranged from childhood to adulthood, the age of final evaluation was 27.3±11,5 years and the follow up period lasted for 25 years. Molecular analysis identified that the major factor contributing to the clinical expression of homozygous β-thalassemia intermedia in Greece is the inheritance of mild β-thalassemia mutations. The great majority of mutations 61.8% were β+ (silent, β++ and β+) mutations with sufficient production of β chain. The most prevalent mutation was IVSI-6 (17.8%). Other common mutations were IVSI-110 (14.1%), -101 (9.4%), CD39 (9.4%), IVSI-1 (8.4%) and IVSII-1 (6.3%). An important differentiation exists in the type and frequency of mutations between patients with the two clinical phenotypes of β-thalassemia intermedia. Silent and very mild mutations (-101, +6, IVSI-6, -87, polyA, -28) prevail in mild β-thalassemia intermedia I2 and account for 45.6% of I2 mutations. In severe β-thalassemia intermedia, β+ mutations are more prevalent and especially mutations that induce the production of γ chain and HbF like IVSII-1, (δβ)0 and δ0β+ Corfu. The coinheritance of α-thalassemia in 6.4% of our patients did not have any significant contribution in amelioration of clinical expression of β-thalassemia intermedia with the exception of one patient with the rare case of coinheritance of a severe form of β-thalassemia and hemoglobinopathy H who was diagnosed at the age of 50 years. An exacerbation of clinical severity was notified in 4 β-thalassemia heterozygous patients with triplicated a gene (ααα/αα) or (ααα/ααα). Mean hemoglobin at diagnosis was 8.0±1.5 gr/dl for type I1 patients and 9.0±1.5 gr/dl for type I2 (p<0.01). Patients preserved hemoglobin levels around 9.0 gr/dl at the final hematological check up. On regular transfusions were 26.5% patients. Most of them discontinued transfusions after splenectomy and at present only 8.2% are transfused. Splenomegaly was one of the most frequent clinical and ultrasound finding and was present in 89.1% patients; the majority (62.2%) was splenectomized. Osteoporosis was present in 89.8% and extramedullary hematopoiesis consisted of paravertebral masses in the posterior mediastinum in 18.4%. Iron overload was assessed with ferritin levels. Patients without transfusions and chelation had mean ferritin 466.4±687.1 μg/L (16.0-3097.0), those with sporadic transfusions without chelation 723.8±588.3 μg/L (112.0-2489.0) and those on regular transfusions and chelation 1130.7±637.7 (412.0-3441.0). On final evaluation 36.7% patients were on chelation. Endocrinopathies were not as frequent as in thalassemia major. Short stature (<3rd percentile) was found in only 6.1% patients. Subclinical hypothyroidism was present in 22.8%, hypogonadism in 18.8% and glucose intolerance in 9.2% patients. Gallstones were present in 39.8% of patients and 45.9% had undergone cholocystectomy at a mean age of 21.1±8.8 years. Echocardiography of the heart disclosed systolic left ventricular dysfunction (ejection fraction <55% or shortening fraction <30%) in 7.4% patients. In conclusion, in the Greek population, β-thalassemia intermedia presents broad clinical, hematological and molecular heterogeneity. The inheritance of mild β-thalassemia mutations is the major factor contributing to the mild clinical expression. The characterization of genotype in β-thalassemia is most valuable to the evaluation of prognosis and the implementation of appropriate treatment in Greek β-thalassemia intermedia children.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Georgakopoulou, Theano
  • Γεωργακοπούλου, Θεανώ

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24424

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Georgakopoulou, Theano; Γεωργακοπούλου, Θεανώ. Μελέτη της συχνότητας και βαρύτητας των επιπλοκών της ενδιάμεσης β-μεσογειακής αναιμίας σε Έλληνες ασθενείς: συσχέτιση με το γονότυπο. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/24424